Article

Carl Zeiss Meditec unveils latest line of ophthalmic advancements

Carl Zeiss Meditec presents its newest ophthalmic advancements at this year?s American Academy of Ophthalmology meeting, including anterior chamber OCT, a non-mydriatic fundus camera, and a number of new networkable systems.

Chicago-Carl Zeiss Meditec presented its newest ophthalmic advancements at this year’s American Academy of Ophthalmology meeting, including anterior chamber OCT, a non-mydriatic fundus camera, and a number of new networkable systems.

Among the highlighted products:

• The Visante OCT device offers OCT technology for the anterior chamber of the eye, allowing physicians to image, measure, and document corneal flap thickness and residual stromal thickness for the first time pre-, during, and post-LASIK and cataract surgery. FDA approval is pending.

• The Visucam Pro NM non-mydriatic fundus camera provides ophthalmologists with accurate fundus imaging without the need for pupil dilation. The camera allows for digital image recording of the retina and posterior segment, which assists in the diagnosis and documentation of diabetic retinopathy, age-related macular degeneration, and glaucoma. FDA approval is pending.

• Networking solutions are designed to increase practitioner workflow and efficiency. Both the Visante OCT and Visucam Pro NM are networkable, as are other new systems and software solutions from the company.

All products are available to view at the Carl Zeiss Meditec Booth 3534.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
I. Paul Singh, MD, speaks about glaucoma treatment and successful ophthalmic / optometric comanagement at the 19th Annual Controversies in Modern Eye Care meeting
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
© 2025 MJH Life Sciences

All rights reserved.